Filtered By:
Vaccination: Meningitis Vaccine
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 126 results found since Jan 2013.
Survey: Many U.S. Adults Not Planning to Get Flu Vaccine
Vaccine knowledge and anticipated rates of vaccination even lower for pneumococcal disease
Source: The Doctors Lounge - Oncology - October 4, 2019 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nursing, Oncology, Pathology, Pediatrics, Pharmacy, Pulmonology, Rheumatology, Institutional, Source Type: news
Defining Polysaccharide Antibody Deficiency: Measurement of Anti-Pneumococcal Antibodies and Anti- Salmonella typhi Antibodies in a Cohort of Patients with Recurrent Infections
ConclusionThe lack of evidence-based gold standards for the diagnosis of SAD represents a challenge in clinical practice. In our cohort, we confirmed the insufficient correlation between different methods of specific PPV response measurement, and showed that theS. typhi Vi response was not contributive. Caution in the interpretation of results is warranted until more reliable diagnostic methods can be validated.
Source: Journal of Clinical Immunology - November 7, 2019 Category: Allergy & Immunology Source Type: research
M406 what came first the immunodeficiency or immunosuppression
64 year old male with polymyositis previously treated with rituximab 5 years prior presented with hypogammaglobulinemia. Polymyositis was poorly controlled and the patient needed clearance prior to restarting rituximab. The patient had no significant infection history. Screening laboratories included a low IgG of 610, low IgM of 31 and protection to 4/14 post vaccination pneumococcal titers.
Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: M. Karasov, J. Carlson Source Type: research
New Recommendations for Pneumococcal Vaccine in Older Adults New Recommendations for Pneumococcal Vaccine in Older Adults
Review recent changes in ACIP ' s recommendations for pneumococcal conjugate vaccine use in older adults.Morbidity & Mortality Weekly Report
Source: Medscape Allergy Headlines - December 11, 2019 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news
Updated Pneumococcal Vaccine Recommendations for Older Adults Updated Pneumococcal Vaccine Recommendations for Older Adults
What do the new PCV13 recommendations mean, and how do you implement them in your practice? Here ' s what you need to know.CDC Expert Commentary
Source: Medscape Allergy Headlines - January 31, 2020 Category: Allergy & Immunology Tags: Infectious Diseases Commentary Source Type: news
Dosage Schedule Linked to Rate of PCV Breakthrough Infections Dosage Schedule Linked to Rate of PCV Breakthrough Infections
A dosing schedule that includes three primary doses of pneumococcal conjugate vaccine (PCV) is associated with fewer breakthrough infections in the first year of life than are schedules with two primary doses, according to a new study of surveillance data.Reuters Health Information
Source: Medscape Allergy Headlines - February 15, 2020 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news
Priming with Prevnar ® improves global pneumococcal vaccine responses to Pneumovax® in Asthmatic Adults
Priming with pneumococcal conjugate PCV13 vaccine elicits T-cell dependent durable immune responses. We sought to explore whether administering PCV13 prior to PPSV23 leads to higher, more durable pneumococcal responses in asthmatic adults.
Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Alexandra Graden, Caitlin McNulty, Catherine Weiler, Miguel Park, Kay Bachman, Avni Joshi, Melissa Snyder Source Type: research
Comparison of Clinical Outcomes of Specific Antibody Deficiency (SAD) by Two Different Definitions
SAD is frequently associated with chronic and recurrent rhinosinusitis (CRS) and is defined as inadequate post-vaccination percentage of protective ( ≥1.3 ug/mL) pneumococcal antibody serotypes /total tested serotypes (post-pPA). Although
Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Diana Chernikova, Dennys Estevez, richard Stiehm, Charles Song Source Type: research
Evaluation of definitions and risk factors of specific antibody deficiency in adult patients with chronic respiratory symptoms
SAD is common among patients with recurrent respiratory infections and is defined by the degree of inadequate response to polysaccharide pneumococcal vaccines.
Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Charles Song, Dennys Estevez, Diana Chernikova, Francesca Hernandez, Rie Sakai-Bizmark, richard Stiehm Source Type: research
Clinical characteristics of patients with poor response to pneumococcal polysaccharide vaccine
Several primary immunodeficiencies (PIDs) are related poor responses of polysaccharide antibodies, such as variable common immunodeficiency (CVID), selective IgA deficiency, IgG subclass deficiency, and specific antibody deficiency (SAD). The aim of this study was to describe the clinical characteristics patients with poor polysaccharide antibody response
Source: Journal of Allergy and Clinical Immunology - January 31, 2020 Category: Allergy & Immunology Authors: Rafaela Guimaraes, Mariana Pimentel, Carolina Aranda, Dirceu Sole Source Type: research
From the pages of AllergyWatch
For this month's issue of Annals, which focuses on vaccines, there are 3 article summaries from recent AllergyWatch columns that reviewed studies on various aspects of vaccines. The first reports data from a pivotal study on the improved efficacy of the new recombinant subunit herpes zoster vaccine. The second review describes a report of a unique vaccine for cats that induces immunoglobulin G –blocking antibodies for Fel d 1. The third review reports discrepant results of pneumococcal titers from different laboratories.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research
Diagnosis and management of Specific Antibody Deficiency
Specific antibody deficiency is a primary immunodeficiency disease recognized by the International Union of Immunology Societies and defined by recurrent respiratory infections with normal immunoglobulins, but diminished antibody responses to polysaccharide antigens after vaccination with the 23 valent pneumococcal polysaccharide vaccine. Clinical immunologists struggle with diagnosis and treatment, because the definition of an adequate response to immunization remains controversial. Specific antibody deficiency is managed clinically with close follow-up and prompt treatment of infections, antibiotic prophylaxis, or immune...
Source: Immunology and Allergy Clinics of North America - June 8, 2020 Category: Allergy & Immunology Authors: Elena E. Perez, Mark Ballow Source Type: research
Flu Vaccine Only 39% Effective This Past Season, CDC Panel Says Flu Vaccine Only 39% Effective This Past Season, CDC Panel Says
The influenza vaccine was even less effective against A/H1N1pmd09 virus but was better against B/Victoria virus, according to a CDC panel. They also voted on a new meningococcal vaccine.Medscape Medical News
Source: Medscape Allergy Headlines - June 25, 2020 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Asplenia and Hyposplenism
The number of disorders associated with congenital or acquired asplenia and functional hyposplenism has increased substantially over the past couple decades. Previously, screening for asplenia and hyposplenism was a barrier to identifying patients at risk. Recent methods for measuring splenic function have emerged as accurate and reliable. Identifying patients prevents overwhelming postsplenectomy infection or invasive pneumococcal disease. Approaches to protect patients with asplenia or hyposplenism include patient education of risks and signs/symptoms of infection, vaccination, and antibiotic prophylaxis. Physicians have...
Source: Immunology and Allergy Clinics of North America - July 10, 2020 Category: Allergy & Immunology Authors: Jacqueline D. Squire, Mandel Sher Source Type: research
M034 pneumococcal debacle – reaction to a common vaccine
Streptococcus pneumonia is the leading cause of bacterial pneumonia worldwide. In the US, the PPSV-23 vaccine is indicated for adults older than 65 and those with underlying conditions that put them at increased risk for pneumococcal disease. This is the case of a patient with a febrile systemic and localized reaction to the PPSV-23 vaccine.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2020 Category: Allergy & Immunology Authors: M. Adame Source Type: research
